{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:14:42Z","timestamp":1780377282603,"version":"3.54.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Homozygous or compound heterozygous mutations in high temperature requirement serine peptidase A1 (<jats:italic toggle=\"yes\">HTRA1<\/jats:italic>) gene are responsible for cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Recently, increasing evidence has shown that heterozygous <jats:italic toggle=\"yes\">HTRA1<\/jats:italic> mutations are also associated with cerebral small vessel disease (CSVD) with an autosomal dominant pattern of inheritance. This study was aimed to analyze the genetic and clinical characteristics of <jats:italic toggle=\"yes\">HTRA1<\/jats:italic>-related autosomal dominant CSVD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We presented three new Chinese cases of familial CSVD with heterozygous <jats:italic toggle=\"yes\">HTRA1<\/jats:italic> mutations and reviewed all clinical case reports and articles on <jats:italic toggle=\"yes\">HTRA1<\/jats:italic>-related autosomal dominant CSVD included in PUBMED by the end of March 1, 2020. CARASIL probands with genetic diagnosis reported to date were also reviewed. The genetic and clinical characteristics of <jats:italic toggle=\"yes\">HTRA1<\/jats:italic>-related autosomal dominant CSVD were summarized and analyzed by comparing with CARASIL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Forty-four <jats:italic toggle=\"yes\">HTRA1<\/jats:italic>-related autosomal dominant CSVD probands and 22 CARASIL probands were included. Compared with typical CARASIL, <jats:italic toggle=\"yes\">HTRA1<\/jats:italic>-related autosomal dominant probands has a higher proportion of vascular risk factors (<jats:italic toggle=\"yes\">P\u200a&lt;\u200a<\/jats:italic>0.001), a later onset age (<jats:italic toggle=\"yes\">P\u200a&lt;\u200a<\/jats:italic>0.001), and a relatively slower clinical progression. Alopecia and spondylosis can be observed, but less than those in the typical CARASIL. Thirty-five heterozygous mutations in <jats:italic toggle=\"yes\">HTRA1<\/jats:italic> were reported, most of which were missense mutations. Amino acids located close to amino acids 250\u2013300 were most frequently affected, followed by these located near 150\u223c200. While amino acids 250\u223c300 were also the most frequently affected region in CARASIL patients, fewer mutations precede the 200th amino acids were detected, especially in the Kazal-type serine protease domain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">HTRA1<\/jats:italic>-related autosomal dominant CSVD is present as a mild phenotype of CARASIL. The trend of regional concentration of mutation sites may be related to the concentration of key sites in these regions which are responsible for pathogenesis of <jats:italic toggle=\"yes\">HTRA1<\/jats:italic>-related autosomal dominant CSVD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000001176","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T12:00:32Z","timestamp":1603713632000},"page":"178-184","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["HTRA1-related autosomal dominant cerebral small vessel disease"],"prefix":"10.1097","volume":"134","author":[{"given":"Jing-Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Cheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.58.5.817","article-title":"Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy","volume":"58","author":"Yanagawa","year":"2002","journal-title":"Neurology"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJMoa0801560","article-title":"Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease","volume":"360","author":"Hara","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/neup.12473","article-title":"Histopathologic features of an autopsied patient with cerebral small vessel disease and a heterozygous HTRA1 mutation","volume":"38","author":"Ito","year":"2018","journal-title":"Neuropathology"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1073\/pnas.161016098","article-title":"Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia","volume":"98","author":"Liu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1074\/jbc.M709299200","article-title":"HtrA1 inhibits mineral deposition by osteoblasts: requirement for the protease and PDZ domains","volume":"283","author":"Hadfield","year":"2008","journal-title":"J Biol Chem"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1212\/WNL.0b013e3181ff96ac","article-title":"A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population","volume":"75","author":"Mendioroz","year":"2010","journal-title":"Neurology"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1212\/WNL.0b013e318215281d","article-title":"A novel mutation in the HTRA1 gene causes CARASIL without alopecia","volume":"76","author":"Nishimoto","year":"2011","journal-title":"Neurology"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1755-5949.2012.00373.x","article-title":"A novel mutation in the HTRA1 gene identified in Chinese CARASIL pedigree","volume":"18","author":"Wang","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1177\/0300060513480926","article-title":"A novel mutation of the high-temperature requirement A serine peptidase 1 (HTRA1) gene in a Chinese family with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)","volume":"41","author":"Chen","year":"2013","journal-title":"J Int Med Res"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/WNL.0000000000000202","article-title":"Two novel HTRA1 mutations in a European CARASIL patient","volume":"82","author":"Bianchi","year":"2014","journal-title":"Neurology"},{"key":"R11-20250603","first-page":"67","article-title":"Mutation in the HTRA1 gene in a patient with degenerated spine as a component of CARASIL syndrome","volume":"24","author":"Bayrakli","year":"2014","journal-title":"Turk Neurosurg"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/STROKEAHA.114.006735","article-title":"Shifting the CARASIL paradigm: report of a non-Asian family and literature review","volume":"46","author":"Menezes Cordeiro","year":"2015","journal-title":"Stroke"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00415-015-7769-5","article-title":"A novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient","volume":"262","author":"Khaleeli","year":"2015","journal-title":"J Neurol"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s10072-015-2121-5","article-title":"A frameshift mutation in HTRA1 expands CARASIL syndrome and peripheral small arterial disease to the Chinese population","volume":"36","author":"Cai","year":"2015","journal-title":"Neurol Sci"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1212\/WNL.0000000000004710","article-title":"CARASIL families from India with 3 novel null mutations in the HTRA1 gene","volume":"89","author":"Preethish-Kumar","year":"2017","journal-title":"Neurology"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000477358","article-title":"A CARASIL patient from americas with novel mutation and atypical features: case presentation and literature review","volume":"44","author":"Ibrahimi","year":"2017","journal-title":"Cerebrovasc Dis"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.017","article-title":"A Chinese CARASIL patient caused by novel compound heterozygous mutations in HTRA1","volume":"27","author":"Xie","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104354","article-title":"A case of leukoencephalopathy and small vessels disease caused by a novel HTRA1 homozygous mutation","volume":"28","author":"Gunduz","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1212\/NXG.0000000000000345","article-title":"Novel mutation in HTRA1 in a family with diffuse white matter lesions and inflammatory features","volume":"5","author":"Ziaei","year":"2019","journal-title":"Neurol Genet"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/brain\/awv155","article-title":"Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease","volume":"138","author":"Verdura","year":"2015","journal-title":"Brain"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jns.2016.01.037","article-title":"Unusual case of cerebral small vessel disease with a heterozygous nonsense mutation in HTRA1","volume":"362","author":"Tateoka","year":"2016","journal-title":"J Neurol Sci"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2169\/internalmedicine.4041-19","article-title":"A case of cerebral small vessel disease related to a heterozygous nonsense mutation in HTRA1","volume":"59","author":"Ohta","year":"2020","journal-title":"Intern Med"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/1971400917700168","article-title":"The first Greek case of heterozygous cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy: an atypical clinico-radiological presentation","volume":"30","author":"Bougea","year":"2017","journal-title":"Neuroradiol J"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jns.2018.11.008","article-title":"A new Italian family with HTRA1 mutation associated with autosomal-dominant variant of CARASIL: are we pointing towards a disease spectrum?","volume":"396","author":"Favaretto","year":"2019","journal-title":"J Neurol Sci"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"e6632","DOI":"10.1590\/1414-431x20176632","article-title":"Heterozygous HTRA1 missense mutation in CADASIL-like family disease","volume":"51","author":"Wu","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clineuro.2018.07.009","article-title":"Heterozygous HTRA1 mutations with mimicking symptoms of CARASIL in two families","volume":"172","author":"Kono","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2018.02.043","article-title":"Cerebral small vessel disease caused by a novel heterozygous mutation in HTRA1","volume":"388","author":"Thaler","year":"2018","journal-title":"J Neurol Sci"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/STROKEAHA.118.021283","article-title":"Characterization of Heterozygous HTRA1 Mutations in Taiwanese Patients With Cerebral Small Vessel Disease","volume":"49","author":"Lee","year":"2018","journal-title":"Stroke"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1212\/WNL.0000000000002694","article-title":"Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL","volume":"86","author":"Nozaki","year":"2016","journal-title":"Neurology"},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/cns.12722","article-title":"Heterozygous mutations of HTRA1 gene in patients with familial cerebral small vessel disease","volume":"23","author":"Di Donato","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s10072-018-3294-5","article-title":"A new case of autosomal dominant small vessel disease carrying a novel heterozygous mutation in HTRA1 gene: 2-year follow-up","volume":"39","author":"Pati","year":"2018","journal-title":"Neurol Sci"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10072-017-3231-z","article-title":"Two novel heterozygous HTRA1 mutations in two pedigrees with cerebral small vessel disease families","volume":"39","author":"Zhang","year":"2018","journal-title":"Neurol Sci"},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1212\/NXG.0000000000000382","article-title":"Cerebral small vessel disease due to a unique heterozygous HTRA1 mutation in an African man","volume":"6","author":"Oluwole","year":"2020","journal-title":"Neurol Genet"},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/383707a0","article-title":"Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia","volume":"383","author":"Joutel","year":"1996","journal-title":"Nature"},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/14737159.2014.922880","article-title":"Interpretation of NOTCH3 mutations in the diagnosis of CADASIL","volume":"14","author":"Rutten","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nsmb.2013","article-title":"Substrate-induced remodeling of the active site regulates human HTRA1 activity","volume":"18","author":"Truebestein","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrm3065","article-title":"HTRA proteases: regulated proteolysis in protein quality control","volume":"12","author":"Clausen","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fneur.2019.00693","article-title":"HTRA1 mutations identified in symptomatic carriers have the property of interfering the trimer-dependent activation cascade","volume":"10","author":"Uemura","year":"2019","journal-title":"Front Neurol"},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"e14804","DOI":"10.1038\/s41598-017-14208-z","article-title":"HtrA1 activation is driven by an allosteric mechanism of inter-monomer communication","volume":"7","author":"Cabrera","year":"2017","journal-title":"Sci Rep"},{"key":"R40-20250603","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.str.2012.03.021","article-title":"Structural and functional analysis of HtrA1 and its subdomains","volume":"20","author":"Eigenbrot","year":"2012","journal-title":"Structure"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:35:53Z","timestamp":1748982953000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000001176","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]}}}